🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Monoclonal antibodies can locate tumor cells and either kill them or delive...
Status
Completed
Location
Children's Oncology Group
Start Date
2001-01
Trial ID
NCT00005576
Treatments Being Tested
This phase I clinical trial evaluates the safety and feasibility of adminis...
Status
Terminated
Location
UCLA / Jonsson Comprehensive Cancer Center
Start Date
2017-07-26
Trial ID
NCT03240861
The purpose is to identify a dose of SB-485232 which is safe, tolerable and...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-07-31
Trial ID
NCT00500058
A multicenter, randomized, double-blinded, placebo-controlled study of two ...
Status
Terminated
Location
CHU LIMOGES Service de Réanimation
Start Date
2016-01-14
Trial ID
NCT02797431
Treatments Being Tested
This randomized phase II trial studies how well glycosylated recombinant hu...
Status
Completed
Location
UC San Diego Moores Cancer Center
Start Date
2013-09-10
Trial ID
NCT01881867
Treatments Being Tested
ALT-101 is a first-in-human Phase 1 clinical trial testing a new antibody d...
Status
Recruiting
Location
Children's Hospital Colorado
Start Date
2026-06-01
Trial ID
NCT07586618
Treatments Being Tested
This is a single center Phase I clinical trial of FT516 administered intrap...
Status
Completed
Location
University of Minnesota, Masonic Cancer Center
Start Date
2021-04-02
Trial ID
NCT04630769
Treatments Being Tested
The TRIPS study is a prospective, multi-center, double-blind, adaptively ra...
Status
Recruiting
Location
Children's of Alabama
Start Date
2022-06-14
Trial ID
NCT05267821
This is a Phase I Study evaluating the safety and feasibility of IL-8 recep...
Status
Not Yet Recruiting
Location
UF Health
Start Date
2026-07
Trial ID
NCT07569263
Treatments Being Tested
The goal of this clinical trial is to investigate the immunomodulatory effe...
Status
Recruiting
Location
Intensive Care Medicine, Radboud University Nijmegen Medical Centre
Start Date
2024-10-24
Trial ID
NCT06624436
Treatments Being Tested